- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: GSK-2838232
Total 1340 results
-
Kowa Research Institute, Inc.CompletedType 2 Diabetes MellitusUnited States
-
Sanwa Kagaku Kenkyusho Co., Ltd.Completed
-
Organon and CoCompleted
-
WestVac Biopharma Co., Ltd.Not yet recruiting
-
Gilead SciencesCompletedHepatitis CUnited States, France, United Kingdom, Germany, Canada, Australia, New Zealand, Puerto Rico
-
Gilead SciencesCompletedChronic Hepatitis CNew Zealand
-
Cedars-Sinai Medical CenterRoswell Park Cancer InstituteCompleted
-
Mahidol UniversityCompleted
-
Jawaharlal Nehru Medical CollegeAstraZeneca; Cipla Ltd.CompletedPostpartum HemorrhageIndia
-
GlaxoSmithKlineCompletedMeasles | Rubella | MumpsUnited States, Finland, Estonia, Spain, Mexico, Puerto Rico
-
GlaxoSmithKlineCompletedInfections, StreptococcalSlovakia, Sweden, Denmark, Norway
-
Dr. Reddy's Laboratories LimitedCompleted
-
Gilead SciencesGalapagos NVCompletedCutaneous Lupus ErythematosusUnited States, Canada
-
Ira WinerRecruitingCervical Cancer | Ovarian Cancer | Vulvar Cancer | Endometrial Cancer | Vaginal Cancer | Gestational Trophoblastic DiseaseUnited States
-
Medacta USAActive, not recruiting
-
Institut für Pneumologie Hagen Ambrock eVReinhard Löwenstein-StiftungCompleted
-
Maastricht University Medical CenterCompleted
-
Gilead SciencesCompleted
-
Organon and CoMerck Sharp & Dohme LLCCompletedAtherosclerosis | Hypercholesterolaemia
-
Advantage Dental Services, LLCCompleted
-
National Cancer Institute (NCI)TerminatedMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | BRAF V600E Mutation Present | BRAF V600K Mutation Present | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
GlaxoSmithKlineCompletedMeasles; Mumps; Rubella | Measles-Mumps-Rubella VaccineUnited States, Finland, Taiwan, Estonia, Puerto Rico
-
University of MinnesotaRecruitingCardiovascular Diseases | Smoking | Smoking Cessation | Tobacco Use | Tobacco Use CessationUnited States
-
Gilead SciencesCompleted
-
Gilead SciencesTerminatedFollicular Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Gilead SciencesCompleted
-
Gilead SciencesTerminatedChronic Obstructive Pulmonary Disease | Cystic FibrosisUnited States
-
Gilead SciencesCompletedHepatitis C Virus InfectionGermany, United States, Australia, United Kingdom, Canada, France, New Zealand
-
GlaxoSmithKlineThe PATH Malaria Vaccine Initiative (MVI)CompletedMalariaGhana, Kenya, Mozambique, Tanzania, Burkina Faso, Gabon, Malawi
-
Gilead SciencesTerminatedAdvanced Solid TumorsUnited States, New Zealand
-
Gilead SciencesCompletedHCV InfectionUnited States, Germany, New Zealand
-
Gilead SciencesCompletedHCV InfectionUnited States, New Zealand, Germany
-
Sanwa Kagaku Kenkyusho Co., Ltd.Completed
-
Gilead SciencesCompletedInflammatory DiseaseUnited States, New Zealand, Germany
-
Sanwa Kagaku Kenkyusho Co., Ltd.CompletedNocturia Due to Nocturnal PolyuriaJapan
-
Gilead SciencesCompletedLong QT SyndromeUnited States, Romania, Moldova, Republic of
-
Gilead SciencesCompletedIschemic Heart DiseaseUnited States
-
SK Chemicals Co., Ltd.CompletedErosive GastritisKorea, Republic of
-
Sanwa Kagaku Kenkyusho Co., Ltd.CompletedPruritusUnited Kingdom
-
Dr. Reddy's Laboratories LimitedCompleted
-
Gilead SciencesCompletedLupus Membranous NephropathyUnited States
-
Gilead SciencesCompletedNon-Alcoholic Steatohepatitis (NASH)United States, Canada
-
Gilead SciencesCompletedHepatitis C, ChronicUnited States, Puerto Rico
-
Stanford UniversityNational Institute of Mental Health (NIMH)RecruitingAnorexia NervosaUnited States, Canada
-
Axon Therapies, Inc.RecruitingHeart Failure With Preserved Ejection FractionUnited States
-
U.S. Army Medical Research and Development CommandCompletedEastern Equine EncephalitisUnited States
-
University Health Network, TorontoWithdrawnFallopian Tube Cancer | Primary Peritoneal Cancer | Ovarian Endometrioid Tumor | TP53 MutationCanada
-
GlaxoSmithKlineCompleted
-
Central Hospital, Nancy, FranceCompleted